Video wird geladen...
Video konnte nicht geladen werden
Moderna has just announced that its personalized cancer vaccine passed its Phase 3 clinical trial. The design process for this treatment was assisted by AI, which helped identify the specific proteins to target in each patient's tumor.
61,809 Aufrufe • vor 1 Monat •via X (Twitter)
0 Kommentare
Keine Kommentare verfügbar
Kommentare vom Original-Post werden hier angezeigt

